S 5167 United States Senate · 117th Congress

TEST Act of 2022

Summary
Temporary Emergency Scheduling and Testing of Fentanyl Analogues Act of 2022 or the TEST Act of 2022 This bill (1) extends the temporary scheduling of fentanyl-related substances in schedule I of the Controlled Substances Act for two years; (2) requires the Drug Enforcement Administration to submit synthetic compounds of fentanyl-related substances it has encountered thus far to the Food and Drug Administration for scientific and medical evaluations, if they have not yet been evaluated; and (3) provides for the removal and rescheduling of fentanyl-related substances from schedule I if certain criteria are met, as well as notifications about any such scheduling changes to individuals who were or are being prosecuted for offenses related to such substances.
Bill status in committee 1 of 4 stages cleared
Introduction
Dec 2022
Committee Review
Floor Vote
President
Introduced Dec 1, 2022 Last action Dec 1, 2022
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Dec 1, 2022
Committee
Referred to the Committee on the Judiciary.
upper
Dec 1, 2022
Introduced
Introduced in Senate
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Cory A. Booker
Cory A. Booker
DDemocratic
NJ
n/a